These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21392655)

  • 21. [The effect of a treatment protocol on the prognosis of equine laminitis].
    Oosterlaan-Mayer B; Back W; Sloet van Oldruitenborgh-Oosterbaan MM
    Tijdschr Diergeneeskd; 2002 Nov; 127(21):644-9. PubMed ID: 12449656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The metabolic syndrome: definitions, prevalence and management.
    Levesque J; Lamarche B
    J Nutrigenet Nutrigenomics; 2008; 1(3):100-8. PubMed ID: 19776619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary management of obesity and insulin resistance: countering risk for laminitis.
    Geor RJ; Harris P
    Vet Clin North Am Equine Pract; 2009 Apr; 25(1):51-65, vi. PubMed ID: 19303550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology.
    Ren J; Kelley RO
    Obesity (Silver Spring); 2009 Jun; 17(6):1114-23. PubMed ID: 19214173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polycystic ovary syndrome and the metabolic syndrome.
    Weerakiet S
    J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S189-93. PubMed ID: 21213522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Horse Advisory Committee: "acute lameness"].
    van Schie JT; Barneveld A
    Tijdschr Diergeneeskd; 2003 Jul 15-Aug 1; 128(14-15):449-53. PubMed ID: 12920926
    [No Abstract]   [Full Text] [Related]  

  • 29. The relationships between insulin resistance and components of metabolic syndrome in Taiwanese Asians.
    Pei D; Kuo SW; Wu DA; Lin TY; Hseih MC; Lee CH; Hsu WL; Chen SP; Sheu WH; Li JC
    Int J Clin Pract; 2005 Dec; 59(12):1408-16. PubMed ID: 16351672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of metformin on measurements of insulin sensitivity and beta cell response in 18 horses and ponies with insulin resistance.
    Durham AE; Rendle DI; Newton JE
    Equine Vet J; 2008 Jul; 40(5):493-500. PubMed ID: 18482898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of oral sugar test response for detection of equine metabolic syndrome in obese Crioulo horses.
    Cantarelli C; Dau SL; Stefanello S; Azevedo MS; De Bastiani GR; Palma HE; Brass KE; De La Côrte FD
    Domest Anim Endocrinol; 2018 Apr; 63():31-37. PubMed ID: 29287187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin resistance in obesity as the underlying cause for the metabolic syndrome.
    Gallagher EJ; Leroith D; Karnieli E
    Mt Sinai J Med; 2010; 77(5):511-23. PubMed ID: 20960553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of equine metabolic syndrome on inflammatory responses of horses to intravenous lipopolysaccharide infusion.
    Tadros EM; Frank N; Donnell RL
    Am J Vet Res; 2013 Jul; 74(7):1010-9. PubMed ID: 23802673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse.
    Vick MM; Adams AA; Murphy BA; Sessions DR; Horohov DW; Cook RF; Shelton BJ; Fitzgerald BP
    J Anim Sci; 2007 May; 85(5):1144-55. PubMed ID: 17264235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. American College of Endocrinology position statement on the insulin resistance syndrome.
    Einhorn D; Reaven GM; Cobin RH; Ford E; Ganda OP; Handelsman Y; Hellman R; Jellinger PS; Kendall D; Krauss RM; Neufeld ND; Petak SM; Rodbard HW; Seibel JA; Smith DA; Wilson PW
    Endocr Pract; 2003; 9(3):237-52. PubMed ID: 12924350
    [No Abstract]   [Full Text] [Related]  

  • 36. ECEIM consensus statement on equine metabolic syndrome.
    Durham AE; Frank N; McGowan CM; Menzies-Gow NJ; Roelfsema E; Vervuert I; Feige K; Fey K
    J Vet Intern Med; 2019 Mar; 33(2):335-349. PubMed ID: 30724412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of intravenous lipopolysaccharide infusion on glucose and insulin dynamics in horses with equine metabolic syndrome.
    Tadros EM; Frank N; De Witte FG; Boston RC
    Am J Vet Res; 2013 Jul; 74(7):1020-9. PubMed ID: 23802674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic implications of dietary trans-fatty acids.
    Dorfman SE; Laurent D; Gounarides JS; Li X; Mullarkey TL; Rocheford EC; Sari-Sarraf F; Hirsch EA; Hughes TE; Commerford SR
    Obesity (Silver Spring); 2009 Jun; 17(6):1200-7. PubMed ID: 19584878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Age, Season, Body Condition, and Endocrine Status on Serum Free Cortisol Fraction and Insulin Concentration in Horses.
    Hart KA; Wochele DM; Norton NA; McFarlane D; Wooldridge AA; Frank N
    J Vet Intern Med; 2016; 30(2):653-63. PubMed ID: 26860336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity; epiphenomenon or cause of metabolic syndrome?
    Lois K; Young J; Kumar S
    Int J Clin Pract; 2008 Jun; 62(6):932-8. PubMed ID: 18479286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.